Claim your company profile
AfterRaise/Weekly/Week 37, 2026

The AfterRaise week

Week 37, 2026

61 rounds, $15.4B of announced capital. The largest: Mistral raised €3.0B. Sorted by size; every figure links to its source.

FundingPublic signal46 days ago
Mistral
€3.0B · Series D · Paris, France · AI & Data Infrastructure
What changed

Raised €3.0B in Series D funding, led by Samsung Electronics.

The company said the funding supports expand frontier research, scale compute capacity for training powerful models, expand infrastructure, and accelerate its commercial growth and international footprint.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceInfrastructure and computeEnterprise salesData partnershipsProduct leadershipMarket-entry advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signal46 days ago
Crusoe Energy Systems
$3.0B · Undisclosed · Denver, USA · Energy & Climate
What changed

Raised $3.0B, led by Atreides Management and Valor Equity Partners.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligencePlatform and infrastructure scalingInfrastructure hiringAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceGrid and utility partnershipsIndustrial partnershipsPlatform engineeringCloud and compute partnersSecurity review
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Cognition
$2.0B · Series E · San Francisco, USA · AI & Data Infrastructure
What changed

Raised $2.0B in Series E funding.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligencePlatform and infrastructure scalingInfrastructure hiringAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceInfrastructure and computeSecurity reviewData partnershipsPlatform engineeringCloud and compute partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Motive
$1.3B · Undisclosed · San Francisco, USA · AI & Data Infrastructure
What changed

Raised $1.3B.

The company said the funding supports advance its AI platform, scale its go-to-market teams, and extend its reach with global enterprise operations.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringCommercial team build-out
Where help may be relevant AfterRaise intelligenceEnterprise salesData partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Positron AI
$875M · Series C · Reno, USA · Semiconductors & Hardware
What changed

Raised $875M in Series C funding, led by NEA.

The company said the funding supports expand operations and its development efforts.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceHardware engineeringIndustrial partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Mach Industries
$600M · Series C · Huntington Beach, USA · Defence, Space & Aerospace
What changed

Raised $600M in Series C funding.

The company said the funding supports accelerate the development of platforms across long-range strike, counter-UAS, and other mission areas, while expanding its manufacturing infrastructure.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceCertification and airworthinessSecurity clearance hiringManufacturing scale-upMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal46 days ago
Aukera
€460M · Debt · Brussels, Belgium · Energy & Climate
What changed

Raised €460M in Debt funding, led by Catalin Breaban and Pascal Emsens.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceGrid and utility partnershipsIndustrial partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource
FundingPublic signal46 days ago
The Exploration Company
$450M · Series C · Paris, France · Defence, Space & Aerospace
What changed

Raised $450M in Series C funding, led by Bessemer Venture Partners.

The company said the funding supports expand operations and its development efforts.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceMarket-entry advisersLocal employment infrastructureIn-market partnershipsCertification and airworthinessGovernment relations
Approach preferences not yet specified
Company pageSource
FundingPublic signal46 days ago
Gimlet Labs
$300M · Series B · San Francisco, USA · AI & Data Infrastructure
What changed

Raised $300M in Series B funding, led by Andreessen Horowitz (a16z).

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringPlatform and infrastructure scaling
Where help may be relevant AfterRaise intelligenceInfrastructure and computeSecurity reviewData partnershipsProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
Encoded Therapeutics
$275M · Series F · South San Francisco, USA · Biotech & Pharma
What changed

Raised $275M in Series F funding, led by GV and another healthcare fund.

The company said the funding supports support the pivotal study of ETX101 in infants and young children with SCN1A+ Dravet syndrome, an expansion study in children and adolescents up to 18 years of age, commercial scale-up of internal GMP manufacturing capabilities, and pipeline advancement, including ETX301 toward a 2027 IND submission for post-amputation neuroma pain.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceClinical operationsCMC and manufacturingQuality systemsScientific hiringLicensing and BD partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
Celero Communications
$275M · Series C · Irvine, USA · AI & Data Infrastructure
What changed

Raised $275M in Series C funding, led by Atreides Management.

The company said the funding supports accelerate its product roadmap, R&D investments, and production readiness for higher-bandwidth, lower-power optical connectivity across next-generation AI infrastructure.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringResearch programme expansion
Where help may be relevant AfterRaise intelligenceInfrastructure and computeSecurity reviewData partnershipsProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
Cylake
$245M · Undisclosed · Sunnyvale, USA · Cybersecurity
What changed

Raised $245M.

The company said the funding supports support continued product development for its complete, AI-native, fully sovereign cybersecurity platform, as well as ongoing team growth.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceChannel partnershipsThreat intelligence partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
Solstice Oncology
$225M · Series A · Boston, USA · Biotech & Pharma
What changed

Raised $225M in Series A funding, led by RA Capital Management.

The company said the funding supports advance its lead candidate, porustobart, across two clinical indications.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Ayar Labs
$150M · Undisclosed · San Jose, USA · Semiconductors & Hardware
What changed

Raised $150M.

The company said the funding supports support its transition to high-volume manufacturing, including investments in product development, validation, scaling the manufacturing ecosystem, and opening a new Bengaluru Design Center.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringManufacturing capacity expansion
Where help may be relevant AfterRaise intelligenceCertificationHardware engineeringIndustrial partnershipsProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal46 days ago
Forus
$150M · Series C · NYC, USA · AI & Data Infrastructure
What changed

Raised $150M in Series C funding, led by Bain Capital Ventures.

The company said the funding supports expand to all specialties and care settings, extend what its AI agents can do across the entire path to treatment, and accelerate investment in its team.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceInfrastructure and computeData partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
TAR
$120M · Series A · Austin, USA · Energy & Climate
What changed

Raised $120M in Series A funding, led by Spark Capital.

The company said the funding supports expand operations and its development efforts.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceGrid and utility partnershipsIndustrial partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signal46 days ago
BrainChild Bio
$116M · Series A · Seattle, USA · Biotech & Pharma
What changed

Raised $116M in Series A funding, led by an undisclosed private family fund and foundation.

The company said the funding supports support the ILLUMINATE Phase 2 study evaluating BCB‑276 for the treatment of diffuse intrinsic pontine glioma (DIPG) and to support the continued development of BCB-214 for glioblastoma.

Likely next AfterRaise intelligenceAggressive multi-front expansionSenior executive hiringRepeatable go-to-market build
Where help may be relevant AfterRaise intelligenceClinical operationsRegulatory affairsCMC and manufacturingQuality systemsMedical affairs
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Clay
$115M · Series D · NYC, USA · AI & Data Infrastructure
What changed

Raised $115M in Series D funding, led by Wellington.

The company said the funding supports build AI agents for business growth, expand platform capabilities, and fund a $1 million scholarship program to train GTM engineers.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceInfrastructure and computeEnterprise salesData partnershipsProduct leadershipMarket-entry advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Perry Weather
$110M · Undisclosed · Dallas, USA · Enterprise Software
What changed

Raised $110M, led by Silversmith Capital Partners.

The company said the funding supports accelerate the development of AI-powered capabilities across its product suite, hire more than 50 new roles through 2027, and support its rapid growth across engineering, product, and services.

Likely next AfterRaise intelligenceTeam growth across core functionsSenior leadership appointmentsProduct launches and new tiers
Where help may be relevant AfterRaise intelligenceCloud infrastructureChannel partnershipsExecutive searchTalent partnersEmployer infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
Savvy Wealth
$100M · Series C · NYC, USA · Fintech & Insurance
What changed

Raised $100M in Series C funding, led by Halo Fund.

The company said the funding supports expand operations and its development efforts.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceBanking partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsProduct leadership
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Inspiren
$70M · Series C · NYC, USA · Healthcare & Medtech
What changed

Raised $70M in Series C funding, led by NewView Capital.

The company said the funding supports scale its go-to-market, continue advancing its hardware ecosystem, and deepen its AI platform capabilities Led by Michael Wang and Alex Hejnosz, Inspiren provides an AI-powered ecosystem designed for senior living operators, communities, and residents.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringCommercial team build-out
Where help may be relevant AfterRaise intelligenceClinical hiringProvider partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource
FundingPublic signal46 days ago
Moonwalk Biosciences
$70M · Series B · South San Francisco, USA · Biotech & Pharma
What changed

Raised $70M in Series B funding, led by Alpha Wave and YK Bioventures.

The company said the funding supports support advancement of its lead obesity candidate, MW101, into first-in-human clinical studies in late 2027, expand its pipeline of tissue-targeted siRNA medicines, and further advance its proprietary discovery platform.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringLicensing and BD partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
TwoStep Therapeutics
$62M · Series A · San Carlos, USA · Biotech & Pharma
What changed

Raised $62M in Series A funding.

The company said the funding supports advance its lead multi-specific peptide-drug conjugate, TS-104, through Phase 1 clinical development in oncology, advance its radioligand program, and expand into new peptide conjugates.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringLicensing and BD partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Heron Power
$60M · Debt · Scotts Valley, USA · Other
What changed

Raised $60M in Debt funding.

The company said the funding supports convert a facility into a mass production factory and scale operations.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringManufacturing capacity expansion
Where help may be relevant AfterRaise intelligenceCommercial leadershipGo-to-market partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
Bluecore Energy
$50M · Seed · Long Beach, USA · Energy & Climate
What changed

Raised $50M in Seed funding, led by Silverton Partners.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAccelerated hiring across functionsFounding team growthFirst commercial motion
Where help may be relevant AfterRaise intelligenceRegulatory affairsGrid and utility partnershipsProject financeField operationsCertification
Approach preferences not yet specified
Company pageSource
FundingPublic signal43 days ago
Vheda Health
$47M · Undisclosed · Columbia, USA · Healthcare & Medtech
What changed

Raised $47M.

The company said the funding supports support its national expansion across health plans and geographies and develop new product and analytics capabilities Led by CEO Shameet Luhar, Vheda Health partners with health plans to identify, stratify, and activate their highest-risk and hardest-to-reach members before costly events occur.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceProvider partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsProduct leadership
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Lightfield
$47M · Series A · San Francisco, USA · AI & Data Infrastructure
What changed

Raised $47M in Series A funding, led by Andreessen Horowitz.

The company said the funding supports expand operations and its development efforts.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceInfrastructure and computeData partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
Implicity
$40M · Undisclosed · Paris, France · AI & Data Infrastructure
What changed

Raised $40M, led by IRIS.

The company said the funding supports expand its commercial footprint and hospital network in the US, support commercial hiring, develop US-specific platform features, and advance its AI innovation roadmap, including next-generation heart failure prediction algorithms.

Likely next AfterRaise intelligenceUS market entryTeam growth across core functionsSenior leadership appointments
Where help may be relevant AfterRaise intelligenceInfrastructure and computeEnterprise salesData partnershipsProduct leadershipExecutive search
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
Wint
$36M · Series D · NYC, USA · Other
What changed

Raised $36M in Series D funding, led by LIP Ventures and Inven Capital.

The company said the funding supports accelerate product development and consolidate its market position.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAcquisitions and consolidation
Where help may be relevant AfterRaise intelligenceCommercial leadershipGo-to-market partnershipsFinance and complianceProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal43 days ago
Ethris
€30M · Undisclosed · Munich, Germany · Biotech & Pharma
What changed

Raised €30M.

The company said the funding supports advance the clinical development of its portfolio of respiratory mRNA products.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringResearch programme expansion
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringLicensing and BD partnershipsProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signal46 days ago
Cloverleaf Bio
$33M · Seed · New Haven, USA · Biotech & Pharma
What changed

Raised $33M in Seed funding, led by 4BIO Capital.

The company said the funding supports advance its two lead programs: an inhibitory tRNA asset targeting hepatocellular carcinoma through early clinical testing and an antibody-tRNA conjugate (ATC) asset targeting colorectal cancer through preclinical development.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAccelerated hiring across functions
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signal43 days ago
Antioch
$32M · Series A · NYC, USA · AI & Data Infrastructure
What changed

Raised $32M in Series A funding, led by Greylock.

The company said the funding supports accelerate product development, expand its engineering team, and deepen its simulation capabilities across robotics, drones, industrial automation, and fixed perception applications.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceInfrastructure and computeData partnershipsProduct leadershipMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal43 days ago
Cymphony
$30M · Undisclosed · NYC, USA · Cybersecurity
What changed

Raised $30M, led by Sequoia Capital and SMBC Fin Atlas Beyond Fund.

The company said the funding supports accelerate product development, expand its engineering and go-to-market teams, and help enterprises securely operationalize AI at scale.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceChannel partnershipsEnterprise salesSecurity research hiringThreat intelligence partnershipsMarket-entry advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Epsilon Health
$28M · Undisclosed · San Francisco, USA · Healthcare & Medtech
What changed

Raised $28M, led by AlleyCorp.

The company said the funding supports accelerate market expansion and support its growing practice through hiring, expanded clinical partnerships, and new infrastructure investments.

Likely next AfterRaise intelligenceTeam growth across core functionsSenior leadership appointmentsNew market entry
Where help may be relevant AfterRaise intelligenceProvider partnershipsExecutive searchTalent partnersEmployer infrastructureMarket-entry advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
Neurent Medical
$25M · Undisclosed · USA · Healthcare & Medtech
What changed

Raised $25M.

The company said the funding supports support the continued commercial expansion, accelerate investment in sales and marketing initiatives, strengthen its balance sheet, and provide additional capital to support future growth opportunities.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceClinical hiringProvider partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
Euno
$23M · Series A · USA · Other
What changed

Raised $23M in Series A funding, led by N47.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceRepeatable go-to-market buildFirst senior commercial hires
Where help may be relevant AfterRaise intelligenceCommercial leadershipOperations hiringGo-to-market partnershipsFinance and compliance
Approach preferences not yet specified
Company pageSource
FundingPublic signal44 days ago
Luminary
$22M · Series A · NYC, USA · Fintech & Insurance
What changed

Raised $22M in Series A funding, led by Ten Coves Capital.

The company said the funding supports continue to build on its AI capabilities and integrations, push into administration workflows, and expand its commercial team.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceBanking partnershipsEnterprise salesFinance hiringMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal45 days ago
System
$20M · Undisclosed · San Francisco, USA · Biotech & Pharma
What changed

Raised $20M.

The company said the funding supports accelerate its expansion and build the foundation and infrastructure for its peptide supply chain.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceCMC and manufacturingQuality systemsLicensing and BD partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal46 days ago
Blee
$20M · Series A · NYC, USA · Legal & Compliance
What changed

Raised $20M in Series A funding, led by Fin Capital and SMBC Fin Atlas Beyond Fund.

The company said the funding supports deepen its capabilities across the full content lifecycle, expand into new industries and geographies, and put its product in front of legal, compliance, marketing, and brand leaders at large organizations.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceEnterprise salesProfessional services partnershipsLegal domain hiringMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signal43 days ago
GenHealth.ai
$16M · Series A · Boston, USA · Healthcare & Medtech
What changed

Raised $16M in Series A funding, led by Flare Capital Partners.

The company said the funding supports grow its engineering and go-to-market teams, extend its agents into additional workflows for provider groups and health plans, and continue improving its underlying model.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringCommercial team build-out
Where help may be relevant AfterRaise intelligenceClinical hiringProvider partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource

The Daily Brief

This page, in your inbox.

Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.